North America Dry Eye Syndrome Market Report by Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Drug Type (Lubricant Eye Drops, Anti-inflammatory Drugs, Autologous Serum Eye Drops, and Others), Product (Liquid Drops, Gels, Liquid Wipes, Eye Ointments, and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Country 2024-2032
The North America dry eye syndrome market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Key Regions Analysed
United States
Canada
Analysis for Each Country
Market by Disease Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Market by Drug Type
Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Market by Product
Liquid Drops
Gels
Liquid Wipes
Eye Ointments
Others
Market by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
What are the key regions in the North America dry eye syndrome market?
What has been the impact of COVID-19 on the North America dry eye syndrome market?
What is the breakup of the North America dry eye syndrome market on the basis of disease type?
What is the breakup of the North America dry eye syndrome market on the basis of drug type?
What is the breakup of the North America dry eye syndrome market on the basis of product?
What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
What are the various stages in the value chain of the North America dry eye syndrome industry?
What are the key driving factors and challenges in the North America dry eye syndrome industry?
What is the structure of the North America dry eye syndrome industry and who are the key players?
What is the degree of competition in the North America dry eye syndrome industry?
What are the profit margins in the North America dry eye syndrome industry?
Dry eye syndrome, also known as keratoconjunctivitis sicca, is a multifactorial tear deficiency disorder of the ocular surface. It is a commonly encountered condition in general ophthalmology practice and entails the lack of a consistent and adequate layer of tears on the eye surface. Dry eye syndrome exhibits a range of symptoms including burning sensation, itchy eyes, inflammation, aching sensations, heaviness, fatigue, soreness, dryness, redness, photophobia and blurred vision. This disease is curable by medicines that are generally available in the form of gels, ointments, liquid drops and wipes.
North America dry eye syndrome market is currently driven by several factors. The changing lifestyles of individuals, especially the increased usage of electronic gadgets, such as computers and TV, has led to a rise in the prevalence of dry eye syndrome. In addition to this, the escalated usage of contact lens among the majority of the population has resulted in the increasing risk of dry eye syndrome. Moreover, the rising geriatric population has become prone to health conditions such as high blood pressure and benign prostatic hyperplasia, which further induces the risk of developing dry eye syndrome. Apart from this, the rapid advancements in the healthcare sector have enabled the easy availability of dry eye syndrome treatment, thus positively influencing the demand in the region.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the North America dry eye syndrome market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Key Regions Analysed
United States
Canada
Analysis for Each Country
Market by Disease Type
Evaporative Dry Eye Syndrome
Aqueous Dry Eye Syndrome
Market by Drug Type
Lubricant Eye Drops
Anti-inflammatory Drugs
Autologous Serum Eye Drops
Others
Market by Product
Liquid Drops
Gels
Liquid Wipes
Eye Ointments
Others
Market by Distribution Channel
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
Competitive Landscape
Competitive Structure
Key Player Profiles
Key Questions Answered in This Report:
How has the North America dry eye syndrome market performed so far and how will it perform in the coming years?
What are the key regions in the North America dry eye syndrome market?
What has been the impact of COVID-19 on the North America dry eye syndrome market?
What is the breakup of the North America dry eye syndrome market on the basis of disease type?
What is the breakup of the North America dry eye syndrome market on the basis of drug type?
What is the breakup of the North America dry eye syndrome market on the basis of product?
What is the breakup of the North America dry eye syndrome market on the basis of distribution channel?
What are the various stages in the value chain of the North America dry eye syndrome industry?
What are the key driving factors and challenges in the North America dry eye syndrome industry?
What is the structure of the North America dry eye syndrome industry and who are the key players?
What is the degree of competition in the North America dry eye syndrome industry?
What are the profit margins in the North America dry eye syndrome industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRY EYE SYNDROME MARKET
5.1 Market Performance
5.2 Market Breakup by Disease Type
5.3 Market Breakup by Drug Type
5.4 Market Breakup by Product
5.5 Market Breakup by Distribution Channel
5.6 Market Breakup by Region
5.7 Market Forecast
6 NORTH AMERICA DRY EYE SYNDROME MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISEASE TYPE
7.1 Evaporative Dry Eye Syndrome
7.2 Aqueous Dry Eye Syndrome
8 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DRUG TYPE
8.1 Lubricant Eye Drops
8.2 Anti-inflammatory Drugs
8.3 Autologous Serum Eye Drops
8.4 Others
9 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY PRODUCT
9.1 Liquid Drops
9.2 Gels
9.3 Liquid Wipes
9.4 Eye Ointments
9.5 Others
10 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISTRIBUTION CHANNEL
10.1 Retail Pharmacies
10.2 Hospital Pharmacies
10.3 Online Pharmacies
11 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY COUNTRY
11.1 United States
11.1.1 Historical Market Trends
11.1.2 Market Breakup by Disease Type
11.1.3 Market Breakup by Drug Type
11.1.4 Market Breakup by Product
11.1.5 Market Breakup by Distribution Channel
11.1.6 Market Forecast
11.2 Canada
11.2.1 Historical Market Trends
11.2.2 Market Breakup by Disease Type
11.2.3 Market Breakup by Drug Type
11.2.4 Market Breakup by Product
11.2.5 Market Breakup by Distribution Channel
11.2.6 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTER’S FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Rivalry
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL DRY EYE SYNDROME MARKET
5.1 Market Performance
5.2 Market Breakup by Disease Type
5.3 Market Breakup by Drug Type
5.4 Market Breakup by Product
5.5 Market Breakup by Distribution Channel
5.6 Market Breakup by Region
5.7 Market Forecast
6 NORTH AMERICA DRY EYE SYNDROME MARKET
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISEASE TYPE
7.1 Evaporative Dry Eye Syndrome
7.2 Aqueous Dry Eye Syndrome
8 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DRUG TYPE
8.1 Lubricant Eye Drops
8.2 Anti-inflammatory Drugs
8.3 Autologous Serum Eye Drops
8.4 Others
9 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY PRODUCT
9.1 Liquid Drops
9.2 Gels
9.3 Liquid Wipes
9.4 Eye Ointments
9.5 Others
10 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY DISTRIBUTION CHANNEL
10.1 Retail Pharmacies
10.2 Hospital Pharmacies
10.3 Online Pharmacies
11 NORTH AMERICA DRY EYE SYNDROME MARKET: BREAKUP BY COUNTRY
11.1 United States
11.1.1 Historical Market Trends
11.1.2 Market Breakup by Disease Type
11.1.3 Market Breakup by Drug Type
11.1.4 Market Breakup by Product
11.1.5 Market Breakup by Distribution Channel
11.1.6 Market Forecast
11.2 Canada
11.2.1 Historical Market Trends
11.2.2 Market Breakup by Disease Type
11.2.3 Market Breakup by Drug Type
11.2.4 Market Breakup by Product
11.2.5 Market Breakup by Distribution Channel
11.2.6 Market Forecast
12 SWOT ANALYSIS
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 VALUE CHAIN ANALYSIS
14 PORTER’S FIVE FORCES ANALYSIS
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Rivalry
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 PRICE ANALYSIS
16 COMPETITIVE LANDSCAPE
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
